In lupus mice treated with P140 peptides after the initial application of IMQ, we observed an increased proportion of splenic neutrophils on day 7, and increased proportion of splenic CX3CR1+ macrophages on day 28 (Fig. 2a). This evidence concerns the gene CX3CR1 and systemic lupus erythematosus.